E286 Dennis Wall, Founder at Cognoa

Today's guest is Dennis Wall, Founder at Cognoa in Palo Alto, California. Founded in 2013, Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. They are dedicated to improving lifelong outcomes for children at risk for developmental delay and their families.

Cognoa's lead products, the first digital diagnosis aid for autism and the first prescription digital therapeutic for children diagnosed with autism, have both received Breakthrough Device designation from the FDA. The company’s AI technology platform will enable Cognoa's product pipeline to address additional unmet needs including ADHD and anxiety. Cognoa plans to commercialize its autism diagnosis aid under the name, Canvas Dx™.

In the episode, Dan will discuss:

The journey to founding Cognoa,

The fascinating work they do in treating autism,

The role of AI, ML and Computer Vision in achieving their mission,

Use cases of the impact they are making in the space,

What excites for the future at Cognoa